黑料网

黑料网 researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.

James F. Howard, Jr, MD, in the 黑料网 Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

James F. Howard Jr., MD, professor in the 黑料网 Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

NC TraCS awarded funding for a $5K-$50K grant application submitted by Rebecca Traub, MD and Xiaoyan Li, MD, PhD.

James F. Howard Jr., MD, professor in the 黑料网 Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.

Dr. Timothy Gershon is co-corresponding author of new research that appeared in Sciences Advances, January 26, 2022.

James F. Howard Jr., MD, professor in the 黑料网 Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.

The Duke/黑料网 ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and 黑料网 studying Alzheimer鈥檚 disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from 黑料网 Pembroke, North Carolina Central University, and East Carolina University.

Over 800 scientists from across the United States and overseas convened virtually for a joint Duke/黑料网 Alzheimer鈥檚 Disease Symposium on May 27.